All Stories

  1. FGF23 measurement in burosumab-treated patients: an emerging treatment may induce a new analytical interference

    Article • Clinical Chemistry and Laboratory Medicine (CCLM), July 2020, De Gruyter

    marie-liesse piketty

  2. False biochemical diagnosis of hyperthyroidism in streptavidin-biotin-based immunoassays: the problem of biotin intake and related interferences

    Article • Clinical Chemistry and Laboratory Medicine (CCLM), June 2017, De Gruyter

    marie-liesse piketty

  3. High-dose biotin therapy leading to false biochemical endocrine profiles: validation of a simple method to overcome biotin interference

    Article • Clinical Chemistry and Laboratory Medicine (CCLM), June 2017, De Gruyter

    marie-liesse piketty

  4. Classification of Patients With GH Disorders May Vary According to the IGF-I Assay

    Article • The Journal of Clinical Endocrinology & Metabolism, May 2017, Endocrine Society

    marie-liesse piketty